PE-backed specialty pharma company Kelso Pharma appointed Giovanni Mauri as general manager of its recently acquired Italian ...

GSK's clinical-stage pipeline is currently focused on oncology, respiratory, immunology and inflammation, and infectious ...

Medical affairs is evolving. Once primarily viewed as a support function in healthcare, it now plays a central role in bridging the gap between research and clinical application. Today's medical ...

UK biotech Epsilogen has bought US-based TigaTx, pooling their resources to create what it says will be a leader in 'pan-isotope' cancer antibodies. Epsilogen rose to prominence a few years ago by ...

Buoyed by new results from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's ...

A proposal by the Biden administration to cover weight-loss medicines for obesity under Medicare has been axed by the White ...

Declining measles vaccination isn't a problem confined to the US. Last month, the World Health Organization (WHO) and UNICEF ...

A key hurdle in front of the EU reforms to pharma legislation has fallen, after the European Parliament’s Environment, Public Health and Food Safety (ENVI) committee approved a series of ...

Metrics to use to track the 2024 VPAG have been subject to discussions, with reference made to two days where talks were held (17th July and 19th July) in the July VPAG operational review meeting ...

An experimental therapy for Parkinson's disease being developed by Roche and Prothena has missed the mark in a phase 2b trial, leaving them sifting through the data for signals of efficacy.

COP27 is in full swing and world leaders are contending with the fact that we will likely not meet the Paris Agreement’s 1.5°C target. The reality is that we will need to focus on limiting a ...

Every breakthrough in medicine, every new treatment that changes lives, starts with research. In this R&D-focused edition of Deep Dive, we explore how researchers are navigating innovation in a ...